Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
XASE:MYO
MYO Stock Chart & Stats
$0.95
-$0.13(-1.86%)
At close: 4:00 PM EST
$0.95
-$0.13(-1.86%)
Day’s Range― - ―
52-Week Range$0.71 - $6.44
Previous CloseN/A
Volume192.17K
Average Volume (3M)635.17K
Market Cap
$36.90M
Enterprise Value$37.36M
Total Cash (Recent Filing)$12.55M
Total Debt (Recent Filing)$12.30M
Price to Earnings (P/E)―
Beta1.43
Next Earnings
Mar 16, 2026EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding38,435,524
10 Day Avg. Volume564,555
30 Day Avg. Volume635,169
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)9.84
Price to Sales (P/S)7.47
P/FCF Ratio-52.30
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue0.90
Enterprise Value/Gross Profit1.35
Enterprise Value/Ebitda-3.70
Forecast
1Y Price Target
$5.75Price Target Upside505.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.28
Revenue Forecast (FY)$46.97M
Bulls Say, Bears Say
Bulls Say
Manufacturing And Cost EfficiencyNew manufacturing capacity combined with insourcing and assembly time reductions is expected to improve gross margins and raise monthly production capability.
Market OpportunityAn estimated addressable U.S. market of about $10 billion underscores sizeable growth potential as adoption expands across orthotics and prosthetics patients.
ReimbursementInclusion of MyoPro in Medicare Part B benefits after the March 2024 CMS ruling expands reimbursement coverage and could materially increase patient access.
Bears Say
Liquidity And Cash BurnProjected average cash burn of $3.0 million per quarter through 2026 could pressure liquidity and prompt the need for external financing if revenue growth does not accelerate.
Myomo News
MYO FAQ
What was Myomo Inc’s price range in the past 12 months?
Myomo Inc lowest stock price was $0.71 and its highest was $6.44 in the past 12 months.
What is Myomo Inc’s market cap?
Myomo Inc’s market cap is $36.90M.
When is Myomo Inc’s upcoming earnings report date?
Myomo Inc’s upcoming earnings report date is Mar 16, 2026 which is in 56 days.
How were Myomo Inc’s earnings last quarter?
Myomo Inc released its earnings results on Nov 10, 2025. The company reported -$0.09 earnings per share for the quarter, beating the consensus estimate of -$0.108 by $0.018.
Is Myomo Inc overvalued?
According to Wall Street analysts Myomo Inc’s price is currently Undervalued.
Does Myomo Inc pay dividends?
Myomo Inc does not currently pay dividends.
What is Myomo Inc’s EPS estimate?
Myomo Inc’s EPS estimate is -0.09.
How many shares outstanding does Myomo Inc have?
Myomo Inc has 38,435,524 shares outstanding.
What happened to Myomo Inc’s price movement after its last earnings report?
Myomo Inc reported an EPS of -$0.09 in its last earnings report, beating expectations of -$0.108. Following the earnings report the stock price went down -7.609%.
Which hedge fund is a major shareholder of Myomo Inc?
Currently, no hedge funds are holding shares in MYO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Myomo Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.75 (505.26% Upside)
$5.75 (505.26% Upside)
Blogger Sentiment
Neutral
MYO Sentiment 50%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 62.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $8.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.39%
12-Months-Change
Fundamentals
Return on Equity
-100.51%
Trailing 12-Months
Asset Growth
108.90%
Trailing 12-Months
Company Description
Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
MYO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with notable revenue growth and strategic expansions, particularly in international markets and the O&P channel. However, challenges such as decreased gross margin, increased operating loss, and high cash burn were significant concerns. The company's reaffirmation of financial guidance and steps to optimize costs and advertising were positive, but the issues with Medicare Advantage revenue and increased losses present challenges.View all MYO earnings summariesMYO Stock 12 Month Forecast
Average Price Target
$5.75
▲(505.26% Upside)
Technical Analysis
Electrocore
―
Modular Medical
―
Vicarious Surgical
―
Adagio Medical Holdings
―
Inspira Technologies Oxy BHN
―
Ownership Overview
17.14% Insiders
5.57% Mutual Funds
0.37% Other Institutional Investors
70.08% Public Companies and
Individual Investors